Biogen U.S. Corporation

Form 483 issued August 26, 2022 · Morrisville, North Carolina

Inspection
Aug 15 – Aug 26, 2022
Observations
1
Pages
2
FEI number
3010164829

In short: On August 26, 2022, FDA issued a Form 483 with 1 observation to Biogen U.S. Corporation in Morrisville, North Carolina (FEI 3010164829) after an inspection that ran Aug 15 – Aug 26, 2022. The investigators were Song Y. Lavalais and Veronica Fuentes. Most observations concern facilities & equipment; the most-cited regulation is 21 CFR 211.68 (automatic, mechanical, and electronic equipment).

At a glance

1 of 1 observations on this 483 concern facilities & equipment.

Facilities & equipment1

Most cited: 21 CFR 211.68 (1×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Input to and output from related systems of formulas and records or data are…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Biogen U.S. Corporation?

FDA listed 1 observation on this Form 483, mostly about facilities & equipment. The most-cited regulation is 21 CFR 211.68 (automatic, mechanical, and electronic equipment). The opening words of each observation are shown on this page.

Who inspected Biogen U.S. Corporation?

Song Y. Lavalais and Veronica Fuentes are named on this Form 483, for the inspection of Aug 15 – Aug 26, 2022. Each investigator has a profile showing what they cite most.

When was Biogen U.S. Corporation inspected by FDA?

The inspection ran Aug 15 – Aug 26, 2022, and the Form 483 is dated August 26, 2022.

How do I get the full Form 483 for Biogen U.S. Corporation?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free